Viewing Study NCT00002267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-05-12 @ 2:22 PM
Study NCT ID: NCT00002267
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Sponsor: Pharmacia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mycobacterium Avium-intracellulare Infection View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rifabutin View
None AIDS-Related Opportunistic Infections View
None Mycobacterium avium-intracellulare Infection View
None Acquired Immunodeficiency Syndrome View
None Antitubercular Agents View